About Windtree Therapeutics, Inc. Windtree Therapeutics, Inc. is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for ...

Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

Liminatus Pharma and CEA Industries announce $1B combined BNB treasury allocations, driving exchange token market to $161B cap.

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

Binance Coin (BNB) surged over 7% to a new all-time high of $855, outperforming major cryptocurrencies and extending its lead ...

BNB's price rose over 6.6% in 24 hours, driven by corporate treasury purchases and a new trade deal between the US and EU.

Windtree Therapeutics has said it is raising another $520 million to buy up BNB, the fifth-largest digital coin, to put on ...

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, ...